Why the study?
Does transcatheter aortic valve replacement reduce all-cause mortality or disabling stroke in low-risk patients with aortic stenosis compared to surgical aortic valve replacement?
Does transcatheter aortic valve replacement reduce all-cause mortality or disabling stroke in low-risk patients with aortic stenosis compared to surgical aortic valve replacement?
In low-risk patients with aortic stenosis, TAVR demonstrates durable benefits compared to surgery for the composite of all-cause mortality or disabling stroke at 3 years.
Answers are grounded in this paper and cite their sources.
Strengthens case for TAVR in low-risk aortic stenosis; extends RCT evidence to 3-year durability.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Forrest et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: